| Subject: | FDA Issues an Alert Regarding Use of Heparin and Sodium Chloride IV Flush Syringes from IV Flush, LLC |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 9 Feb 2005 - 10:00 am |
| The FDA has issued an alert regarding the use of prefilled IV flush syringes that contain both Heparin and Sodium Chloride. The solutions are used to flush IV catheters and may be contaminated. The manufacturer IV Flush, LLC has voluntarily recalled the IV flush syringes due to lack of proper clearance from the FDA. Additionally, it has been noted that patients using the IV Heparin solution have reported Pseudomonas fluorescens infections - with the infections possibly related to the Heparin... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
